Searchable abstracts of presentations at key conferences in endocrinology

ea0022p136 | Cardiovascular endocrinology and lipid metabolism | ECE2010

Serum ferritin and risk of the metabolic syndrome in cross-sex hormone-treated transsexuals

Fernandez Antonio Becerra , Lopez Gilberto Perez , Menacho Miriam , Lucio Perez Maria Jesus , Araque Nuria Asenjo , Rodriguez Molina Jose Miguel , Llopis Agelan Jose Luis

Moderately elevated body iron stores may be associated with several components of the metabolic syndrome (MetSyn). Elevated serum ferritin levels (Fer) independently predicted incident type 2 diabetes in prospective studies in apparently healthy men and women.Aims: To analyze the association between Fer and components of MetSyn in transsexuals before and after 2-year cross-sex treatment (CST).Methods: Before starting the CST in 90 ...

ea0022p474 | Female reproduction | ECE2010

Serum ferritin in female-to-male transsexuals with polycystic ovary syndrome

Lopez Gilberto Perez , Fernandez Antonio Becerra , Menacho Miriam , Perez Maria Jesus Lucio , Araque Nuria Asenjo , Molina Jose Miguel Rodriguez , Agelan Jose Luis Llopis

Elevated serum ferritin levels has been reported in premenopausal women presenting polycystic ovary syndrome (PCOS) and hyperandrogenism, and thus may be involved in the development of insulin resistance, type 2 diabetes y cardiovascular disease. In female-to-male transsexuals (FMTs) PCOS is frequent and this issue has been little studied.Aims: To study the serum ferritin in FMTs with PCOS and their relations with markers of insulin resistance (IR) and m...

ea0022p675 | Obesity | ECE2010

Relationship between obesity and classic cardiovascular risk factors

Gomez-Barrado Jose Javier , Polo Jose , Gomez-Martino Juan Ramon , Barquilla Alfonso , Vega Jorge , Turegano Soledad , Gallego Rocio , Garciperez de Vargas Francisco Javier

Obesity is a disease very prevalent and often associated with morbidities and cardiovascular risk factors. We explore the relationship between the presence of obesity with cardiovascular risk factors more frequent and the presence of cardiovascular disease (CVD) after (ischemic heart disease, cerebrovascular disease, peripheral artery).Material and methods: A sample of 1491 individuals of both sexes, over 14 years, elected by random sampling three of the...

ea0022p689 | Obesity | ECE2010

Influence of age of onset of metabolic syndrome

Gomez-Barrado Jose Javier , Gomez-Martino Juan Ramon , Polo Jose , Barquilla Alfonso , Turegano Soledad , Vega Jorge , de Vargas Francisco Javier Garciperez , Mendoza Javier

The metabolic syndrome (MS) is a pathological entity that carries a high cardiovascular risk, and whose risk factors may occur at an early age. No data are available in our area on the influence of age on the prevalence of MS.Objectives: To determine the prevalence of MS in our area, by age group and compare the frequency of occurrence of MS in young adults (<40 years) (J) and mature adults (>40 years) (M).Methods: Observat...

ea0020p92 | Thyroid | ECE2009

Autoimmune thyroiditis, Graves’ disease and cardiovascular risk factors

Neves Celestino , Alves Marta , Pereira Luis Miguel , Carvalho Ema , Pimentel Isolina , Carvalho Renata , Guimaraes Cristina , Ramos Joao Pedro , Carvalho Davide , Delgado Jose Luis , Medina Jose Luis

Aims: To examine whether treated autoimmune thyroiditis (AIT) and Graves’ disease (GD) are associated with increased cardiovascular risk factors.Patients and methods: We analysed the levels of total cholesterol (TC), HDL, LDL, triglycerides (TG), ApoB, ApoA1, Lp[a], homocysteine, CRP, folic acid and vitamin B12 in 50 patients with GD and in 130 patients with AIT, after normalization of thyroid function. Patients with GD were treated with propylthiou...

ea0020p132 | Thyroid | ECE2009

Thyroid function, serum lipids and insulin resistance in patients with autoimmune thyroiditis

Neves Celestino , Alves Marta , Pereira Luis Miguel , Pimentel Isolina , Carvalho Ema , Carvalho Renata , Guimaraes Cristina , Ramos Joao Pedro , Carvalho Davide , Delgado Jose Luis , Medina Jose Luis

Objective: The aim of this study was to examine the hypothesis that thyroid function, in euthyroid subjects with autoimmune thyroiditis (AIT), is associated with insulin resistance, serum lipid concentrations, and other cardiovascular (CV) risk factors. Subjects and Methods: We recorded thyroid function tests, BMI, insulin resistance markers comprising the Homeostasis Model Assessment for insulin resistance (HOMA-IR), the Quantitative Insulin Sensitivity Check Index (QUICKI), ...

ea0014p533 | (1) | ECE2007

Effects of glucocorticoid replacement on bone mass in women after long-term remission of Cushing’s syndrome

Barahona Maria-Jose , Sucunza Nuria , Lluch Pilar , Fedrnandez-Real Jose-Manuel , Ricart Wifredo , Puig Teresa , Wäger Ana M , van Elzelingen Caroline , Farrerons Jordi , Webb Susan M

High dose and long-term glucocorticoid (GC) therapy reduce bone mass and negatively affect the metabolic profile. Patients in remission after successful treatment of Cushing’s syndrome (CS) often present hypoadrenalism and require long-term GC replacement.Objective: To evaluate the effect of GC therapy on bone and metabolic parameters in women after long-term remission of CS. Materials and methods: Thirty-two women (mean age: 50±14 years) with ...

ea0056p361 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Phenotypic and autoimmunity analysis of patients with type 1 diabetes mellitus onset

Maria Diaz Perdigones Cristina , Hern Carmen , Damas Fuentes Miguel , Jose Picon Cesar Maria , Luis Pinzon Martin Jose , Molina Vega Maria , Tinahones Madueno Francisco

Introduction: Type 1 diabetes mellitus (T1DM) is considered, in general, a disease of children and young adults with normal body mass index (BMI), linked to a genetic susceptibility based on autoimmunity. However, we know that it can be diagnosed at any age and we must differentiate it from type 2 diabetes mellitus.Objetives: To investigate the phenotypic characteristics and the presence of specific autoimmunity in T1DM patients diagnosed in our hospital...

ea0056p1093 | Thyroid (non-cancer) | ECE2018

Should tocilizumab be a second-line treatment of active, moderate-to-severe Graves’ Orbitopathy?

Caceres Rocio , Herrero Ana , Recio-Cordova Jose Maria , Sanchez-Marcos Ana , Higueruela Cecilia , Beaulieu Myriam , Iglesias Rosana , Robles Cristina , Garcia-Duque Maria , Corrales-Hernandez Juan Jose

Introduction: Graves’ orbitopathy (GO) is the most common extrathyroidal manifestation of Graves’ disease. The first-line treatment are intravenous corticoids in active moderate-severe GO. Tocilizumab is a humanized monoclonal antibody against the IL-6 receptor which has been approved for the treatment of rheumatoid arthritis and is in its research stage for patients with corticosteroid-refractory GO.Objectives: To assess the experience with to...

ea0056p1142 | Thyroid cancer | ECE2018

Increased incidence of thyroid cancer in a spanish tertiary hospital, valladolid, spain: evolution and clinical characteristics, 2002–2016

Calvo Susana Garcia , Diaz-Soto Gonzalo , Sanz Maria Alvarez-Quinones , Martinez-Pino Isabel , Torres Beatriz , Lopez Juan Jose , Mateos Juan Jose , Luis Daniel de

Introduction: Thyroid cancer is the most frequent malignant endocrine neoplasia. Its incidence has significantly risen worldwide in the last decades.Objective: To estimate the incidence of thyroid cancer in Valladolid’s east area population, Spain, over the period 2002–2016.Methods: A retrospective descriptive research was performed in the Clinical Universitary Hospital of Valladolid (HCUVa). Clinical data was obtained fr...